AXKO-0046 | m-entrepreneurship.com

Product Name :
AXKO-0046

Search keywords :
AXKO-0046

drugId :
null

Target Vo:
L-lactate dehydrogenase B chain

Target Vo Short Name :
L-lactate dehydrogenase B chain

Moa_Name:
L-lactate dehydrogenase B chain inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Axcelead Drug Discovery Partners Inc

Active Company_Name :
Axcelead Drug Discovery Partners Inc

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Odesivimab site
Dnmt3a Rabbit mAb supplier
FKBP52 Antibody: FKBP52 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 52 kDa, targeting to FKBP52. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse.

Author: Betaine hydrochloride

Related Posts